Clover Biopharmaceuticals

Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing transformative biologic therapies. The company mainly focuses on oncology and autoimmune diseases. It is utilizing its proprietary Trimer-Tag technology platform to develop novel biologics targeting trimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars.